Back to top
more

Bausch Health Cos Inc. (BHC)

(Real Time Quote from BATS)

$31.45 USD

31.45
36,782

-0.08 (-0.25%)

Updated Jun 15, 2021 09:59 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.41%
2Buy19.02%
3Hold10.72%
4Sell6.46%
5Strong Sell3.06%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 23% (194 out of 251)

Industry: Medical - Generic Drugs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for BHC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Bausch Health Cos Inc. falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 1,816 3,244 723 797 542
Receivables 1,577 1,839 1,865 2,130 2,517
Notes Receivable 0 0 0 0 0
Inventories 1,094 1,107 934 1,048 1,061
Other Current Assets 855 779 689 771 957
Total Current Assets 5,342 6,969 4,211 4,746 5,077
Net Property & Equipment 1,567 1,466 1,353 1,403 1,312
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 2,137 1,690 1,676 433 146
Intangibles 21,489 23,327 25,143 30,804 34,678
Deposits & Other Assets 664 411 109 111 2,316
Total Assets 31,199 33,863 32,492 37,497 43,529
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 0 0 0 0 0
Accounts Payable 337 503 411 365 324
Current Portion Long-Term Debt 0 1,234 228 209 1
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 4,576 4,511 3,197 3,694 3,175
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 109
Total Current Liabilities 4,913 6,248 3,836 4,268 3,609
Mortgages 0 0 0 0 0
Deferred Taxes/Income 528 705 885 1,180 5,434
Convertible Debt 0 0 0 0 0
Long-Term Debt 23,925 24,661 24,077 25,235 29,845
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,228 1,113 879 870 1,383
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 30,594 32,727 29,677 31,553 40,271
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 10,227 10,172 10,121 10,090 10,038
Capital Surplus 454 429 413 380 351
Retained Earnings -8,013 -7,452 -5,664 -2,725 -5,129
Other Equity -2,063 -2,013 -2,055 -1,801 -2,002
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 605 1,136 2,815 5,944 3,258
Total Liabilities & Shareholder's Equity 31,199 33,863 32,492 37,497 43,529
Total Common Equity 605 1,136 2,815 5,944 3,258
Shares Outstanding 355.40 352.50 349.70 348.50 347.60
Book Value Per Share 1.70 3.22 8.05 17.06 9.37

Fiscal Year End for Bausch Health Cos Inc. falls in the month of December.

All items in Millions except Per Share data.

3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Assets          
Cash & Equivalents 1,893 1,816 1,988 1,907 1,923
Receivables 1,499 1,577 1,733 1,369 1,712
Notes Receivable 0 0 0 0 0
Inventories 1,076 1,094 1,224 1,226 1,124
Other Current Assets 924 855 726 776 745
Total Current Assets 5,392 5,342 5,671 5,278 5,504
Net Property & Equipment 1,556 1,567 1,550 1,496 1,450
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 2,150 2,137 1,913 1,874 1,740
Intangibles 20,482 21,489 22,083 22,381 22,760
Deposits & Other Assets 617 664 345 367 411
Total Assets 30,197 31,199 31,562 31,396 31,865
Liabilities & Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Notes Payable 0 0 0 0 0
Accounts Payable 342 337 379 447 444
Current Portion Long-Term Debt 0 0 0 1 4
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 4,556 4,576 4,353 4,270 4,438
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 4,898 4,913 4,732 4,718 4,886
Mortgages 0 0 0 0 0
Deferred Taxes/Income 520 528 650 694 690
Convertible Debt 0 0 0 0 0
Long-Term Debt 23,738 23,925 24,343 24,357 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1,165 1,182 1,081 25,499
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 30,321 30,594 30,907 30,850 31,075
Shareholders Equity 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 10,289 10,227 10,219 10,217 10,209
Capital Surplus 393 454 435 411 396
Retained Earnings -8,623 -8,013 -7,860 -7,931 -7,605
Other Equity -2,183 -2,063 -2,139 -2,151 -2,210
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity -124 605 655 546 790
Total Liabilities & Shareholder's Equity 30,197 31,199 31,562 31,396 31,865
Total Common Equity -124 605 655 546 790
Shares Outstanding 358.40 355.40 355.10 354.90 352.10
Book Value Per Share -0.35 1.70 1.84 1.54 2.24